Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hidekata Yasuoka

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Rheumatology (Oxford, England)|June 29, 2012
Clinical characteristics and survival of Japanese patients with connective tissue disease and pulmonary arterial hypertension: a single-centre cohortYuichiro Shirai, Hidekata Yasuoka, Yutaka Okano, et al.
Arthritis Research & Therapy|July 13, 2013
Versican is upregulated in circulating monocytes in patients with systemic sclerosis and amplifies a CCL2-mediated pathogenic loopAyako Masuda, Hidekata Yasuoka, Takashi Satoh, et al.
Clinical Rheumatology|June 8, 2020
Clinical effectiveness of iguratimod based on real-world data of patients with rheumatoid arthritisSatoshi Mizutani, Hitoshi Kodera, Yoshiko Sato, et al.
Rheumatology (Oxford, England)|May 2, 2017
Follicular helper T cells in the pathogenesis of IgG4-related diseaseMitsuhiro Akiyama, Katsuya Suzuki, Hidekata Yasuoka, et al.
Frontiers in Immunology|May 3, 2021
Peripheral TIGIT+ T Follicular Helper Cells That Produce High Levels of Interleukin-21 <i>via</i> OX40 Represent Disease Activity in IgG4-Related DiseaseMitsuhiro Akiyama, Katsuya Suzuki, Keiko Yoshimoto, et al.
Arthritis and Rheumatism|November 6, 2004
Autoreactive CD8+ cytotoxic T lymphocytes to major histocompatibility complex class I chain-related gene A in patients with Behçet's diseaseHidekata Yasuoka, Yuka Okazaki, Yutaka Kawakami, et al.
Clinical and Experimental Rheumatology|February 22, 2018
Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sjögren's syndrome adults from a defined populationMitsuhiro Akiyama, Takanori Sasaki, Yuko Kaneko, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 12, 2014
Elevated levels of pentraxin 3 in systemic sclerosis: associations with vascular manifestations and defective vasculogenesisYuichiro Shirai, Yuka Okazaki, Yumiko Inoue, et al.
Modern Rheumatology|April 2, 2014
Tocilizumab is clinically, functionally, and radiographically effective and safe either with or without low-dose methotrexate in active rheumatoid arthritis patients with inadequate responses to DMARDs and/or TNF inhibitors: a single-center retrospective cohort study (KEIO-TCZ study) at week 52Keisuke Izumi, Yuko Kaneko, Hidekata Yasuoka, et al.
Clinical and Experimental Rheumatology|December 3, 2024
CCR4+Tfh2 cells specifically produce IL-4 driving the pathological reaction in IgG4-related diseaseMitsuhiro Akiyama, Keiko Yoshimoto, Hidekata Yasuoka, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Rheumatology (Oxford, England)|June 29, 2012
Clinical characteristics and survival of Japanese patients with connective tissue disease and pulmonary arterial hypertension: a single-centre cohortYuichiro Shirai, Hidekata Yasuoka, Yutaka Okano, et al.
Arthritis Research & Therapy|July 13, 2013
Versican is upregulated in circulating monocytes in patients with systemic sclerosis and amplifies a CCL2-mediated pathogenic loopAyako Masuda, Hidekata Yasuoka, Takashi Satoh, et al.
Clinical Rheumatology|June 8, 2020
Clinical effectiveness of iguratimod based on real-world data of patients with rheumatoid arthritisSatoshi Mizutani, Hitoshi Kodera, Yoshiko Sato, et al.
Rheumatology (Oxford, England)|May 2, 2017
Follicular helper T cells in the pathogenesis of IgG4-related diseaseMitsuhiro Akiyama, Katsuya Suzuki, Hidekata Yasuoka, et al.
Frontiers in Immunology|May 3, 2021
Peripheral TIGIT+ T Follicular Helper Cells That Produce High Levels of Interleukin-21 <i>via</i> OX40 Represent Disease Activity in IgG4-Related DiseaseMitsuhiro Akiyama, Katsuya Suzuki, Keiko Yoshimoto, et al.
Arthritis and Rheumatism|November 6, 2004
Autoreactive CD8+ cytotoxic T lymphocytes to major histocompatibility complex class I chain-related gene A in patients with Behçet's diseaseHidekata Yasuoka, Yuka Okazaki, Yutaka Kawakami, et al.
Clinical and Experimental Rheumatology|February 22, 2018
Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sjögren's syndrome adults from a defined populationMitsuhiro Akiyama, Takanori Sasaki, Yuko Kaneko, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 12, 2014
Elevated levels of pentraxin 3 in systemic sclerosis: associations with vascular manifestations and defective vasculogenesisYuichiro Shirai, Yuka Okazaki, Yumiko Inoue, et al.
Modern Rheumatology|April 2, 2014
Tocilizumab is clinically, functionally, and radiographically effective and safe either with or without low-dose methotrexate in active rheumatoid arthritis patients with inadequate responses to DMARDs and/or TNF inhibitors: a single-center retrospective cohort study (KEIO-TCZ study) at week 52Keisuke Izumi, Yuko Kaneko, Hidekata Yasuoka, et al.
Clinical and Experimental Rheumatology|December 3, 2024
CCR4+Tfh2 cells specifically produce IL-4 driving the pathological reaction in IgG4-related diseaseMitsuhiro Akiyama, Keiko Yoshimoto, Hidekata Yasuoka, et al.
Pageof 9